The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Machine learning prediction of COVID-19 mortality in cancer patients.
 
Rodrigo Dienstmann
Employment - Oncoclínicas
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Speakers' Bureau - Amgen; Ipsen; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Merck
 
Marcia Menezes
Stock and Other Ownership Interests - Grupo Oncoclinicas
 
Matheus Costa e Silva
Employment - Grupo Oncoclinicas
 
Heloisa Cruz
Employment - Grupo Oncoclinicas
 
Rafael Paes
Speakers' Bureau - MSD Oncology
 
Jussaine Alves da Silva
Employment - Grupo Oncoclinicas
 
Anna Carolina R Messias
Employment - Grupo Oncoclinicas
 
Pedro De Marchi
Honoraria - Sanofi
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Amgen; AstraZeneca; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Jorge Alexandre Canedo
No Relationships to Disclose
 
Andreia Cristina De Melo
Honoraria - BMS Brazil; MSD Oncology; Novartis
Speakers' Bureau - BMS Brazil; MSD Oncology
Research Funding - AstraZeneca (Inst); BMS Brazil (Inst); Clovis Oncology (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Alexandre A. Jácome
Speakers' Bureau - Roche; SERVIER
 
Tomas Reinert
Honoraria - AstraZeneca; Libbs; Lilly; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - Lilly; Novartis
Research Funding - AstraZeneca (Inst); Libbs (Inst)
 
Barbara Sodre Figueiredo Ferreira
No Relationships to Disclose
 
Clarissa Mathias
No Relationships to Disclose
 
Carlos H. Barrios
Stock and Other Ownership Interests - Biomarker; MedSIR; Tummi
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Libbs; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech; United Medical
Research Funding - AB Science (Inst); Abbvie (Inst); Abraxis BioScience (Inst); Amgen (Inst); Asana Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clinica Atlantis (Inst); Covance (Inst); Daiichi Sankyo (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); ImClone Systems (Inst); INC Research (Inst); inVentiv Health (Inst); Janssen (Inst); LEO Pharma (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merrimack (Inst); Millennium (Inst); Mylan (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Polyphor (Inst); Roche/Genentech (Inst); Sanofi (Inst); Shanghai Henlius Biotech (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS Brazil; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech
 
Carlos G. M. Ferreira
No Relationships to Disclose
 
Bruno Lemos Ferrari
No Relationships to Disclose